How have ZOM shares performed in 2024?

Zomedica Pharmaceuticals Corp. (ZOM.V)'s stock was trading at C$0.29 at the beginning of 2024. Since then, ZOM shares have increased by 0.0% and is now trading at C$0.29. View the best growth stocks for 2024 here .

What other stocks do shareholders of Zomedica Pharmaceuticals Corp. (ZOM.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zomedica Pharmaceuticals Corp. (ZOM.V) investors own include Heat Biologics (HTBX) , Biocept (BIOC) , Remark (MARK) , Onconova Therapeutics (ONTX) , Vislink Technologies (VISL) , Genius Brands International (GNUS) , Ritter Pharmaceuticals (RTTR) , T2 Biosystems (TTOO) , Guardion Health Sciences (GHSI) and MicroVision (MVIS) .

How do I buy shares of Zomedica Pharmaceuticals Corp. (ZOM.V)?

Shares of ZOM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:ZOM

Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free ZOM Stock Alerts

C$0.28

-0.02 (-6.56%)

(As of 02/5/2020)

Compare

Today's Range: C$0.29
▼
C$0.29
50-Day Range: C$0.29
▼
C$0.29
52-Week Range: C$0.29
▼
C$1.50

Volume: 4,800 shs
Average Volume: 2,858 shs
Market Capitalization: C$36.73 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Zomedica Pharmaceuticals Corp. (ZOM.V) alerts:

Ad InvestorPlace

The #1 Crypto for 2024

5 Tiny Cryptos That Could Soar During 2024 Crypto Bull Run One of the first ever crypto millionaires who bought Bitcoin when it was trading for just $5 in 2011 is back with his next huge prediction. A newly approved government regulation is set to flood trillions of dollars into the crypto markets, leading to the FINAL crypto bull run. One of the "Kings of Crypto" has revealed five tiny cryptos that could soar over the course of 2024. Potentially resulting in gains as big as 10X, 50X, or even 100X over the next 12 months.

Get His #1 Coin For 2024 FREE By Clicking Here

About Zomedica Pharmaceuticals Corp. (ZOM.V) Stock (CVE:ZOM)

Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. It has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was founded in 2015 and is headquartered in Ann Arbor, Michigan.

ZOM Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ZOM Stock News Headlines

November 19, 2023 | morningstar.com

Zomedica Corp Ordinary Shares ZOM

May 10, 2023 | benzinga.com

Zomedica Stock (AMEX:ZOM), Dividends

April 19, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

May 8, 2023 | msn.com

Zomedica acquires Structured Monitoring Products

March 15, 2023 | seekingalpha.com

Zomedica expands topline thanks to acquisitions and organic growth

January 25, 2023 | seekingalpha.com

Squarex Pharmaceutical Seeks IPO For Development Funding

January 19, 2023 | marketwatch.com

Advanced Therapy Medicinal Products Market Detailed Analysis of Current Scenario with Growth Forecasts to 2029

January 15, 2023 | marketwatch.com

Pulmonary Edema Treatment Market Opportunities, Demand and Forecasts 2023-2028 with Top Countries Data

April 19, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

January 9, 2023 | benzinga.com

Corporate Reputation of Pharma in United States, 2021-2022: The Patient Perspective of 40+ Companies 2021 v. 2020

December 14, 2022 | wsj.com

HPGC Renmintongtai Pharmaceutical Corp. A

December 14, 2022 | marketwatch.com

Respiratory Devices Market 2023 To Garner Overwhelming Hike In Revenues by 2026 | 132 Pages Report

November 2, 2022 | msn.com

CVS Health raises annual profit forecast on strength in PBM, insurance units

October 6, 2022 | yahoo.com

Microbion Corporation Announces Granting of a US Patent for a Pharmaceutical Composition of Pravibismane

October 1, 2022 | reuters.com

001067F.KS

September 30, 2022 | wsj.com

Saudi Pharmaceutical Industries & Medical Appliances Corp.

September 15, 2022 | finance.yahoo.com

Nova Mentis Completes Production of Psilocybin Microdose Capsules

September 7, 2022 | finance.yahoo.com

Global Counterfeit Drug Detection Devices Market Valuation to Exceed $1.3 Billion by 2026

September 7, 2022 | finance.yahoo.com

Cipla receives USFDA approval for generic version of Revlimid® (Lenalidomide capsules)

August 12, 2022 | finance.yahoo.com

Eupraxia Pharmaceuticals Reports Second Quarter 2022 Financial Results

August 8, 2022 | benzinga.com

Psychedelic Drugs Global Market to Reach $7.03 Billion by 2026

July 15, 2022 | finance.yahoo.com

Insights on the Veterinary Medicine Global Market to 2027 - by Product, Animal Type, Route of Administration, Distribution Channel and Region

July 11, 2022 | finance.yahoo.com

Dilated Cardiomyopathy Market to Boost at a CAGR of approximately 13% by 2032 | DelveInsight

June 29, 2022 | finance.yahoo.com

Global Decentralized Clinical Trials Market is projected to grow at a CAGR of 6.95% By 2032: Visiongain Reports Ltd

June 10, 2022 | apnews.com

The Worldwide Pharmacovigilance Industry is Expected to Reach $15.8 Billion by 2030 - ResearchAndMarkets.com

April 8, 2022 | msn.com

Annapolis Area Job Openings: Check Out The Latest

February 20, 2022 | nz.finance.yahoo.com

PacerPro Director of Design Releases First in a Series of New Product Enhancements

See More Headlines

Receive ZOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zomedica Pharmaceuticals Corp. (ZOM.V) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: CVE:ZOM
CUSIP: N/A
CIK: N/A
Web: www.zomedica.com
Phone: 734-369-2555
Fax: N/A
Employees: 27
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 4.91
Current Ratio: 15.31
Quick Ratio: 15.25

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: C$0.05 per share
Price / Cash Flow: 5.38
Book Value: C$0.05 per share
Price / Book: 5.82

Miscellaneous

Outstanding Shares: 128,872,000
Free Float: N/A
Market Cap: C$36.73 million
Optionable: Not Optionable
Beta: N/A

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Gerald L. Solensky Jr. (Age 45)
Chairman, Pres & CEO
Mr. Shameze Rampertab B.Sc. MBA (Age 52)
CA, CPA, CFO, Corp. Sec. & Director
Dr. Stephanie Morley D.V.M. (Age 44)
DVM, COO & VP of Product Devel.
Mr. Michael Schilk
VP of Sales
Mr. David Eaton
VP of Marketing

Key Competitors

View All Competitors

ZOM Stock Analysis - Frequently Asked Questions

How have ZOM shares performed in 2024?: Zomedica Pharmaceuticals Corp. (ZOM.V)'s stock was trading at C$0.29 at the beginning of 2024. Since then, ZOM shares have increased by 0.0% and is now trading at C$0.29.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Zomedica Pharmaceuticals Corp. (ZOM.V) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Zomedica Pharmaceuticals Corp. (ZOM.V) investors own include Heat Biologics (HTBX), Biocept (BIOC), Remark (MARK), Onconova Therapeutics (ONTX), Vislink Technologies (VISL), Genius Brands International (GNUS), Ritter Pharmaceuticals (RTTR), T2 Biosystems (TTOO), Guardion Health Sciences (GHSI) and MicroVision (MVIS).
How do I buy shares of Zomedica Pharmaceuticals Corp. (ZOM.V)?: Shares of ZOM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:ZOM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial